Scientific innovationEST. 2009

The evidence behind the medicine.

Verita advances care that is published, peer-reviewed and co-authored with the world’s leading institutions. This is where our protocols are tested, proven, and held to account.

Peer-reviewed · co-authored · independently indexed

  • 19advisory professors
  • 12research institutions
  • 16+years of data
01 — EditorialOur position

We do not market hope. We publish evidence.

Modern medicine is full of claims. Verita was built to do the harder thing: to measure, to test, and to submit our work for independent review. For more than sixteen years our clinicians and scientists have co-authored studies with leading universities and research institutes, advancing protocols only once the evidence justifies them.

That discipline is why several of our treatments reached patients first anywhere in the world, and why our findings appear in peer-reviewed journals rather than promotional brochures. Verita Neuro is ranked first globally in Epidural Stimulation; Verita Life holds one of the most complete bodies of integrative oncology practice in the field.

The directory below brings that record into one place. It is the proof beneath the promise.

02 — By measure

The standing of the work

Global standing
#1
Globally in Epidural Stimulation
The world’s leading centre for this treatment — and the first to deliver it to patients outside a clinical trial.
01Professors & clinicians on the advisory board19
02Research & academic institutions collaborating12
03Treatments first commercialised outside trials4
04Years of clinical & outcome data16+
03 — Featured recordVerita Neuro
Phase II trialNeuromodulation · spinal cord injury

Time course of motor improvement by epidural stimulation after spinal cord injury.

Porceban MM, Angelin LG, … Majeed N & Charles H (Verita Neuro), Lepski GA · Journal of Central Nervous System Disease, 2025

Abstract

Epidural electrical stimulation (EES) is a promising intervention for motor rehabilitation after spinal cord injury, but the extent and trajectory of recovery have remained unclear. This Phase II interim analysis followed five patients with ASIA A or B paraplegia for twelve months after implantation, measuring voluntary movement with lower-extremity Fugl-Meyer (FMA-LE) scores and electromyography.

Motor scores improved from 36 ± 9 at baseline to 64 ± 4 at twelve months (P < 0.05), with the steepest gains in the first three months before plateauing after month five at 68% above baseline. Balance and spasticity improved and no serious adverse events occurred — supporting EES in facilitating early recovery while beginning to define where its limits lie.

Verita Neuro clinicians Dr Nasir Majeed and Hanna Charles are among the study’s co-authors.

Fig. 1FMA-LE · n = 5
Lower-extremity Fugl-Meyer motor scores across twelve months of stimulation-assisted rehabilitation (P < 0.05).
+68%
Motor gain above baseline at plateau
12 mo
Prospective follow-up
0
Serious adverse events
05 — Methodology

How a protocol earns its place.

Nothing reaches a Verita patient on belief alone. Every protocol moves through the same disciplined path, from first hypothesis to independent review.

STEP 01

Discover

Research partnerships with leading universities and institutes surface the protocols with genuine scientific promise.

STEP 02

Validate

Diagnostics, biomarkers and structured clinical study establish whether a protocol is safe and genuinely effective.

STEP 03

Publish

Findings are co-authored with our partners and submitted for independent peer review and journal publication.

STEP 04

Commercialise

Only then does a proven protocol reach patients, often first in the world, under full clinical governance.

07 — Research network

The institutions behind the work.

Our research engine is powered by collaborations with universities, academies and institutes worldwide.

12research & academic institutions collaborating
Explore the partner network
01University of ViennaVienna, AT · Epigenetics
02Imperial College LondonLondon, UK · Clinical research
03Albert Einstein College of MedicineNew York, US · Genetics
04University of São PauloSão Paulo, BR · Neurosurgical oncology
05University of CalgaryCalgary, CA · Neurorehabilitation
06German Society of Anti-Aging MedicineDE · Longevity · GSAAM
07CK Cell Technologies (UNSW)Sydney, AU · Cellular medicine
08Memel BiotechDE · Cell therapy · ATMP
09Bangkok Stem CellsBangkok, TH · Regenerative research

Researching at the frontier? Let’s collaborate.

We work with clinicians, scientists and institutions to co-develop protocols and advance the evidence. Reach our science team to explore a collaboration.